| Literature DB >> 35564996 |
Mieczysław Szyszkowicz1, Anna Lukina1, Tatiana Dinu2.
Abstract
This study focused on investigating possible associations between exposure to urban air pollution and the number of emergency department (ED) visits for various health outcomes. The outcomes were grouped into four chapters of the International Classification of Diseases Tenth Revision (ICD-10) system (i.e., Chapter II-IV: "Neoplasms", "Diseases of the blood", "Endocrine, nutritional and metabolic diseases", and XVIII: "Symptoms, signs and abnormal clinical and laboratory findings"). The data were collected for the city of Toronto, Canada, (2004-2015, 4292 days). Four gaseous air pollutants (carbon monoxide (CO), nitrogen dioxide (NO2), ground level ozone (O3), and sulfur dioxide (SO2)) and fine particulate matter (PM2.5), and two calculated air quality health indexes (AQHI) based on Toronto were used. The statistical models were constructed by applying the conditional Poisson regression. The exposure was assessed over a maximum of 15 days (time lags 0-14 days). An analysis was performed with the following strata: sex, age, and seasons. Relative risks (RR) and their 95% confidence intervals (95%CI) were estimated for an increase in concentration by a one interquartile range (IQR). For the AQHI (composed of NO2, O3, and PM2.5), IQR = 1, the estimations for lag 1 and all patients, are RR = 1.023 (95%CI: 1.008, 1.038), 1.026 (1.012, 1.040), 1.013 (1.003, 1.024), and 1.007 (1.003, 1.010) for Chapters II-IV and XVIII, respectively. The results show that in the four large, analyzed health groups, the impact of air quality mainly occurs over a short period (from current day to a maximum of 3 days after exposure).Entities:
Keywords: abdominal and pelvic pain; ambient air pollution; benign neoplasm; diabetes mellitus; relative risk
Mesh:
Substances:
Year: 2022 PMID: 35564996 PMCID: PMC9105125 DOI: 10.3390/ijerph19095603
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Top 20 frequencies of ED visits classified in Chapters II and III.
|
|
|
|
|
|
|
| D12 | 96,198 | 28.9 | D64 | 36,305 | 48.4 |
| C44 | 26,088 | 7.8 | D57 | 10,261 | 13.7 |
| C50 | 18,970 | 5.7 | D50 | 8490 | 11.3 |
| C67 | 16,003 | 4.8 | D70 | 6390 | 8.5 |
| D25 | 13,043 | 3.9 | D69 | 4350 | 5.8 |
| C34 | 12,117 | 3.6 | D68 | 3152 | 4.2 |
| D41 | 11,075 | 3.3 | D61 | 1473 | 2.0 |
| C18 | 8324 | 2.5 | D86 | 659 | 0.9 |
| D17 | 8269 | 2.5 | D72 | 589 | 0.8 |
| C61 | 7776 | 2.3 | D75 | 500 | 0.7 |
| D24 | 7413 | 2.2 | D53 | 387 | 0.5 |
| D22 | 7259 | 2.2 | D66 | 367 | 0.5 |
| C78 | 5382 | 1.6 | D56 | 358 | 0.5 |
| D05 | 4703 | 1.4 | D58 | 312 | 0.4 |
| C79 | 4654 | 1.4 | D59 | 292 | 0.4 |
| D37 | 4462 | 1.3 | D73 | 217 | 0.3 |
| D06 | 4310 | 1.3 | D52 | 194 | 0.3 |
| D23 | 3964 | 1.2 | D62 | 142 | 0.2 |
| C20 | 3855 | 1.2 | D51 | 123 | 0.2 |
| D27 | 3798 | 1.1 | D80 | 94 | 0.1 |
|
|
|
|
|
|
|
| E11 | 27,299 | 25.6 | R10 | 512,573 | 22.0 |
| E87 | 19,190 | 18.0 | R07 | 398,248 | 17.1 |
| E86 | 13,929 | 13.0 | R51 | 111,339 | 4.8 |
| E14 | 13,686 | 12.8 | R50 | 111,089 | 4.8 |
| E10 | 13,302 | 12.5 | R42 | 99,923 | 4.3 |
| E16 | 4524 | 4.2 | R06 | 94,296 | 4.1 |
| E04 | 3926 | 3.7 | R11 | 92,029 | 4.0 |
| E83 | 3827 | 3.6 | R55 | 85,902 | 3.7 |
| E05 | 1105 | 1.0 | R31 | 75,426 | 3.2 |
| E03 | 775 | 0.7 | R00 | 55,931 | 2.4 |
| E61 | 539 | 0.5 | R53 | 55,390 | 2.4 |
| E06 | 494 | 0.5 | R56 | 52,139 | 2.2 |
| E27 | 430 | 0.4 | R04 | 51,807 | 2.2 |
| E88 | 372 | 0.4 | R05 | 50,436 | 2.2 |
| E28 | 294 | 0.3 | R33 | 44,464 | 1.9 |
| E85 | 296 | 0.3 | R21 | 42,862 | 1.8 |
| E65 | 275 | 0.3 | R45 | 36,870 | 1.6 |
| E07 | 271 | 0.3 | R22 | 31,312 | 1.4 |
| E84 | 250 | 0.2 | R20 | 28,711 | 1.2 |
| E80 | 228 | 0.2 | R41 | 26,015 | 1.1 |
Figure 1Frequencies of the numbers of positive statistically significant (p-value < 0.05) associations summarized by all strata (as per patients’ sex and age, and seasons). Chapters II–IV and XVIII (ICD-10 codes: C00–D48, D50–D89, E00–E90, and R00–R99) are based on the Toronto patients attending ED in a period between 2004 and 2015.
Figure 2Frequencies of the numbers of positive statistically significant (p-value < 0.05) associations summarized by all-time lags expressed as days (0–14). Chapters II–IV and XVIII (ICD-10 codes: C00–D48, D50–D89, E00–E90, and R00–R99) are based on the Toronto patients attending ED in a period between 2004 and 2015.
Figure 3Frequencies of the numbers of positive statistically significant (p-value < 0.05) associations summarized by all air pollutants. Chapters II–IV and XVIII (ICD-10 codes: C00–D48, D50–D89, E00–E90, and R00–R99) are based on the Toronto patients attending ED in the period between 2004 and 2015.
Relative risks (RR) and their 95% confidence intervals (95%CI) for an increase in the AQHI-X level by a one interquartile range (IQR = 1.5). ICD-10 codes: C00–D48; Chapter II Neoplasms Data recorded in Toronto, Canada for the period between April 2004 and December 2015.
| Lags | Lag 0 | Lag 1 | Lag 2 | |||
|---|---|---|---|---|---|---|
| Strata | RR | 95%CI | RR | 95%CI | RR | 95%CI |
| All | 1.048 | (1.032, 1.063) | 1.032 | (1.016, 1.047) | 1.022 | (1.006, 1.037) |
| Female | 1.050 | (1.034, 1.067) | 1.031 | (1.014, 1.047) | 1.021 | (1.004, 1.038) |
| Male | 1.045 | (1.028, 1.062) | 1.033 | (1.016, 1.050) | 1.022 | (1.005, 1.040) |
| Warm All | 1.031 | (1.019, 1.044) | 1.020 | (1.008, 1.033) | 1.025 | (1.012, 1.038) |
| Warm Female | 1.031 | (1.017, 1.045) | 1.020 | (1.006, 1.034) | 1.027 | (1.013, 1.042) |
| Warm Male | 1.032 | (1.018, 1.046) | 1.021 | (1.007, 1.035) | 1.023 | (1.008, 1.037) |
| Cold All | 1.070 | (1.052, 1.090) | 1.048 | (1.029, 1.067) | 1.021 | (1.003, 1.040) |
| Cold Female | 1.078 | (1.058, 1.098) | 1.046 | (1.027, 1.066) | 1.017 | (0.998, 1.037) |
| Cold Male | 1.063 | (1.042, 1.083) | 1.049 | (1.029, 1.070) | 1.025 | (1.005, 1.045) |
| Age 0–10 All | 1.023 | (0.958, 1.092) | 1.063 | (0.996, 1.134) | 1.059 | (0.991, 1.133) |
| Age 0–10 Female | 0.955 | (0.879, 1.037) | 1.025 | (0.943, 1.115) | 1.020 | (0.937, 1.110) |
| Age 0–10 Male0 | 1.094 | (1.010, 1.184) | 1.099 | (1.017, 1.188) | 1.099 | (1.013, 1.192) |
| Age 11–60 All | 1.050 | (1.033, 1.067) | 1.025 | (1.008, 1.042) | 1.019 | (1.002, 1.036) |
| Age 11–60 Female | 1.047 | (1.028, 1.066) | 1.020 | (1.002, 1.039) | 1.015 | (0.996, 1.034) |
| Age 11–60 Male | 1.055 | (1.034, 1.076) | 1.032 | (1.011, 1.054) | 1.025 | (1.004, 1.047) |
| Age 60+ All | 1.046 | (1.030, 1.063) | 1.037 | (1.020, 1.053) | 1.023 | (1.007, 1.040) |
| Age 60+ Female | 1.055 | (1.036, 1.074) | 1.042 | (1.023, 1.061) | 1.027 | (1.008, 1.046) |
| Age 60+Male | 1.040 | (1.022, 1.058) | 1.032 | (1.014, 1.051) | 1.020 | (1.002, 1.038) |
Estimated relative risks (RR) and their 95% confidence intervals (95%CI) for an increase in the AQHI level by a one interquartile range (IQR = 1.0). ICD-10 codes: D50–D89; Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism. Data recorded in Toronto, Canada for the period between April 2004 and December 2015.
| Lags | Lag 0 | Lag 1 | Lag 2 | |||
|---|---|---|---|---|---|---|
| Strata | RR | 95%CI | RR | 95%CI | RR | 95%CI |
| All | 1.025 | (1.011, 1.039) | 1.026 | (1.012, 1.040) | 1.014 | (1.000, 1.028) |
| Female | 1.024 | (1.007, 1.042) | 1.030 | (1.012, 1.048) | 1.007 | (0.989, 1.025) |
| Male | 1.026 | (1.006, 1.046) | 1.021 | (1.001, 1.042) | 1.023 | (1.003, 1.043) |
| Warm All | 1.025 | (1.012, 1.038) | 1.022 | (1.009, 1.035) | 1.013 | (1.000, 1.026) |
| Warm Female | 1.029 | (1.012, 1.046) | 1.027 | (1.010, 1.045) | 0.999 | (0.982, 1.016) |
| Warm Male | 1.021 | (1.002, 1.039) | 1.015 | (0.997, 1.034) | 1.031 | (1.012, 1.050) |
| Cold All | 1.027 | (1.012, 1.042) | 1.032 | (1.017, 1.047) | 1.017 | (1.002, 1.032) |
| Cold Female | 1.022 | (1.004, 1.042) | 1.035 | (1.015, 1.054) | 1.018 | (0.999, 1.037) |
| Cold Male | 1.034 | (1.012, 1.056) | 1.028 | (1.006, 1.050) | 1.015 | (0.993, 1.037) |
| Age 0–10 All | 1.037 | (0.983, 1.094) | 1.032 | (0.978, 1.089) | 1.001 | (0.948, 1.057) |
| Age 0–10 Female | 1.036 | (0.964, 1.115) | 1.015 | (0.943, 1.093) | 0.953 | (0.885, 1.027) |
| Age 0–10 Male0 | 1.039 | (0.969, 1.115) | 1.048 | (0.977, 1.124) | 1.042 | (0.970, 1.119) |
| Age 11–60 All | 1.014 | (0.994, 1.034) | 1.026 | (1.005, 1.046) | 1.024 | (1.004, 1.045) |
| Age 11–60 Female | 1.017 | (0.991, 1.043) | 1.034 | (1.008, 1.061) | 1.022 | (0.996, 1.049) |
| Age 11–60 Male | 1.010 | (0.979, 1.041) | 1.014 | (0.983, 1.046) | 1.028 | (0.997, 1.060) |
| Age 60+ All | 1.033 | (1.014, 1.052) | 1.026 | (1.007, 1.045) | 1.007 | (0.988, 1.026) |
| Age 60+ Female | 1.030 | (1.005, 1.055) | 1.028 | (1.003, 1.053) | 0.999 | (0.975, 1.024) |
| Age 60+Male | 1.036 | (1.009, 1.063) | 1.024 | (0.997, 1.052) | 1.017 | (0.990, 1.044) |
Relative risks (RR) and their 95% confidence intervals (95%CI) for an increase in the AQHI level by a one interquartile range (IQR = 1.0). ICD-10 codes: E00–E90; Chapter IV Endocrine, nutritional and metabolic diseases. Data recorded in Toronto, Canada for the period between April 2004 and December 2015.
| Lags | Lag 0 | Lag 1 | Lag 2 | |||
|---|---|---|---|---|---|---|
| Strata | RR | 95%CI | RR | 95%CI | RR | 95%CI |
| All | 1.014 | (1.003, 1.025) | 1.013 | (1.003, 1.024) | 1.011 | (1.001, 1.022) |
| Female | 1.024 | (1.009, 1.039) | 1.018 | (1.004, 1.033) | 1.009 | (0.995, 1.024) |
| Male | 1.004 | (0.989, 1.019) | 1.008 | (0.993, 1.023) | 1.014 | (0.999, 1.029) |
| Warm All | 1.007 | (0.997, 1.018) | 1.013 | (1.003, 1.023) | 1.012 | (1.002, 1.022) |
| Warm Female | 1.019 | (1.006, 1.033) | 1.016 | (1.002, 1.030) | 1.003 | (0.989, 1.016) |
| Warm Male | 0.995 | (0.981, 1.009) | 1.009 | (0.995, 1.024) | 1.022 | (1.008, 1.037) |
| Cold All | 1.023 | (1.011, 1.035) | 1.012 | (1.001, 1.024) | 1.012 | (1.000, 1.024) |
| Cold Female | 1.030 | (1.014, 1.047) | 1.020 | (1.003, 1.036) | 1.021 | (1.004, 1.037) |
| Cold Male | 1.015 | (0.999, 1.031) | 1.005 | (0.989, 1.021) | 1.003 | (0.987, 1.019) |
| Age 0–10 All | 1.065 | (1.001, 1.133) | 1.026 | (0.963, 1.092) | 1.010 | (0.948, 1.075) |
| Age 0–10 Female | 1.098 | (1.016, 1.187) | 0.988 | (0.912, 1.072) | 0.974 | (0.898, 1.057) |
| Age 0–10 Male0 | 1.034 | (0.955, 1.120) | 1.061 | (0.980, 1.147) | 1.040 | (0.960, 1.127) |
| Age 11–60 All | 1.014 | (0.998, 1.030) | 1.010 | (0.994, 1.026) | 1.018 | (1.002, 1.035) |
| Age 11–60 Female | 1.028 | (1.005, 1.051) | 1.016 | (0.994, 1.039) | 1.021 | (0.998, 1.045) |
| Age 11–60 Male | 1.001 | (0.979, 1.023) | 1.004 | (0.982, 1.026) | 1.016 | (0.993, 1.038) |
| Age 60+ All | 1.012 | (0.998, 1.027) | 1.015 | (1.001, 1.030) | 1.006 | (0.992, 1.021) |
| Age 60+ Female | 1.019 | (1.000, 1.038) | 1.021 | (1.002, 1.040) | 1.003 | (0.984, 1.022) |
| Age 60+Male | 1.005 | (0.984, 1.025) | 1.009 | (0.988, 1.030) | 1.011 | (0.990, 1.032) |
Relative risks (RR) and their 95% confidence intervals (CI) for an increase in fine particulate matter (PM2.5) level by a one interquartile range (IQR = 6.5 ppb). ICD-10 codes: R00–R99; Chapter XVIII Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified. Data recorded in Toronto, Canada for the period between April 2004 and December 2015.
| Lags | Lag 0 | Lag 1 | Lag 2 | |||
|---|---|---|---|---|---|---|
| Strata | RR | 95%CI | RR | 95%CI | RR | 95%CI |
| All | 1.005 | (1.002, 1.008) | 1.006 | (1.003, 1.009) | 1.004 | (1.001, 1.007) |
| Female | 1.005 | (1.002, 1.009) | 1.006 | (1.002, 1.009) | 1.004 | (1.001, 1.008) |
| Male | 1.004 | (1.001, 1.008) | 1.006 | (1.002, 1.009) | 1.003 | (0.999, 1.007) |
| Warm All | 1.002 | (0.999, 1.005) | 1.005 | (1.002, 1.008) | 1.002 | (0.999, 1.005) |
| Warm Female | 1.002 | (0.999, 1.006) | 1.005 | (1.002, 1.009) | 1.004 | (1.001, 1.008) |
| Warm Male | 1.001 | (0.997, 1.004) | 1.004 | (1.001, 1.008) | 1.000 | (0.996, 1.003) |
| Cold All | 1.007 | (1.004, 1.010) | 1.007 | (1.004, 1.009) | 1.004 | (1.001, 1.007) |
| Cold Female | 1.008 | (1.004, 1.011) | 1.006 | (1.003, 1.010) | 1.004 | (1.000, 1.007) |
| Cold Male | 1.006 | (1.003, 1.010) | 1.007 | (1.003, 1.010) | 1.005 | (1.002, 1.009) |
| Age 0–10 All | 1.013 | (1.005, 1.022) | 1.011 | (1.003, 1.020) | 1.011 | (1.002, 1.019) |
| Age 0–10 Female | 1.011 | (1.000, 1.023) | 1.009 | (0.998, 1.020) | 1.011 | (1.000, 1.022) |
| Age 0–10 Male0 | 1.015 | (1.005, 1.025) | 1.013 | (1.003, 1.023) | 1.010 | (1.000, 1.021) |
| Age 11–60 All | 1.004 | (1.001, 1.007) | 1.005 | (1.002, 1.009) | 1.003 | (1.000, 1.006) |
| Age 11–60 Female | 1.006 | (1.002, 1.010) | 1.006 | (1.002, 1.010) | 1.003 | (0.999, 1.007) |
| Age 11–60 Male | 1.002 | (0.998, 1.006) | 1.004 | (1.000, 1.008) | 1.003 | (0.998, 1.007) |
| Age 60+ All | 1.004 | (1.000, 1.008) | 1.006 | (1.001, 1.010) | 1.003 | (0.998, 1.007) |
| Age 60+ Female | 1.004 | (0.999, 1.009) | 1.004 | (0.999, 1.010) | 1.004 | (0.999, 1.009) |
| Age 60+Male | 1.005 | (0.999, 1.010) | 1.007 | (1.001, 1.012) | 1.001 | (0.996, 1.007) |